前言目的研究穴位刺激調(diào)控法治療強(qiáng)迫癥的臨床療效。方法將強(qiáng)迫癥患者65例分為氯米帕明組33例和穴位刺激調(diào)控組32例,進(jìn)行對照研究。用YaleBrown強(qiáng)迫癥量表(YBOCS)評定療效和不良反應(yīng)。結(jié)果氯米帕明組痊愈率為24.2%(8/33例),顯效率為27.3%(9/33例)。穴位刺激調(diào)控組痊愈率為37.5%(12/32例),顯效率為34.4%(11/32例)。第4周末起兩組間的YBOCS評分的差異有顯著性(P<0.05),穴位刺激調(diào)控組療效優(yōu)于氯米帕明組。氯米帕明組不良反應(yīng)發(fā)生率顯著高于穴位刺激調(diào)控組。結(jié)論穴位刺激調(diào)控組療效優(yōu)于氯米帕明組、不良反應(yīng)小,安全性好。
ObjectiveTostudytheclinicaleffectofacupointstimulatingcontrol(ASC)intreatingobsessivecompulsiveneurosis.MethodsThecomparativestudywasconductedin65patientswithobsessivecompulsiveneurosis,theyweredividedintotwogroups,the33patientsinthecontrolgrouptreatedwithchlorimipramineandthe32inthetestedgrouptreatedwithASC.ThetherapeuticefficacyandadversereactionwereassessedaccordingtothestandardforclinicalefficacyevaluationbyYale-Brownscaleforobsess...